UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect

Endocrine, 2021-06, Vol.72 (3), p.604-610

2021

Volltextzugriff (PDF)

Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study

Cardiovascular diabetology, 2023-03, Vol.22 (1), p.69-69, Article 69

2023

Volltextzugriff (PDF)

SGLT2-inhibitors are effective and safe in the elderly: The SOLD study

Pharmacological research, 2022-09, Vol.183, p.106396, Article 106396

2022

Volltextzugriff (PDF)

COVID-19 vaccines and blood glucose control: Friend or foe?

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2363068

2024

Volltextzugriff (PDF)

Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)

Frontiers in endocrinology (Lausanne), 2023-01, Vol.13, p.1099451-1099451

2023

Volltextzugriff (PDF)

Thyrotoxicosis in patients with COVID-19: the THYRCOV study

European journal of endocrinology, 2020-10, Vol.183 (4), p.381-387

2020

Volltextzugriff (PDF)

Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis

Diabetes technology & therapeutics, 2010-10, Vol.12 (10), p.749-753

2010

Volltextzugriff (PDF)

Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy

Diabetes care, 2020-12, Vol.43 (12), p.3042-3049

2020

Volltextzugriff (PDF)

Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists

Diabetes research and clinical practice, 2024-06, Vol.212, p.111689-111689, Article 111689

2024

Volltextzugriff (PDF)

l‐Carnitine: a nutritional modulator of glucocorticoid receptor functions

The FASEB journal, 2003-08, Vol.17 (11), p.1-20

2003

Volltextzugriff (PDF)

367-P: Cardiovascular Risk Categories in Patients with Diabetes According to 2019 ESC/EASD Guidelines in Clinical Practice: Use of a Dedicated App (AWARE)

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort

Pharmacological research, 2018-11, Vol.137, p.270-279

2018

Volltextzugriff (PDF)

Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population

Acta diabetologica, 2019-08, Vol.56 (8), p.931-938

2019

Volltextzugriff (PDF)

I nuovi farmaci antidiabetici nelle persone che vivono con l’infezione da HIV

JHA - Journal of HIV and Ageing, 2023-06

Mirani, Marco

2023

Volltextzugriff (PDF)

Update on vertebral fractures in pituitary diseases: from research to clinical practice

Hormones (Athens, Greece), 2021-09, Vol.20 (3), p.423-437

2021

Volltextzugriff (PDF)

Biochemical Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors by Cardiovascular Risk Profile and Volume Status in a Real-World Diabetic Population

Journal of cardiovascular pharmacology, 2022-07, Vol.80 (1), p.140-147

2022

Volltextzugriff (PDF)

AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus

Acta diabetologica, 2023-09, Vol.60 (9), p.1257-1266

2023

Volltextzugriff (PDF)

112 Safety and biochemical efficacy of sodium–glucose cotransporter 2 inhibitors based on cardiovascular risk profile and volume status in a real-world diabetic population

European heart journal supplements, 2021-12, Vol.23 (Supplement_G)

2021

Volltextzugriff (PDF)

617 Effects of SGLT2 inhibitors on left and right ventricular function in a real-world diabetic population

European heart journal supplements, 2021-12, Vol.23 (Supplement_G)

2021

Volltextzugriff (PDF)

Reply to letter to the editor by Bonaventura et al

Acta diabetologica, 2020, Vol.57 (1), p.111-112

2020

Volltextzugriff (PDF)

COVID-19 ed endocrinologia: il caso della tiroide, del diabete e dell’ipovitaminosi D

L'Endocrinologo, 2021, Vol.22 (5), p.383-388

2021

Volltextzugriff (PDF)

Tissue glucocorticoid resistance/hypersensitivity syndromes

Journal of steroid biochemistry and molecular biology, 2003-06, Vol.85 (2), p.457-467

2003

Volltextzugriff (PDF)

HIV-1 Protein Vpr Suppresses IL-12 Production from Human Monocytes by Enhancing Glucocorticoid Action: Potential Implications of Vpr Coactivator Activity for the Innate and Cellular Immunity Deficits Observed in HIV-1 Infection

The Journal of immunology (1950), 2002-12, Vol.169 (11), p.6361-6368

2002

Volltextzugriff (PDF)

Long-term treatment with glucagon-like peptide-1 (GLP-1) receptor agonists: a real-life study

Endocrine Abstracts, 2022-05

2022

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(19)
Humans
(14)
Endocrinology & Metabolism
(12)
Diabetes
(8)
Covid-19
(6)
Diabetes Mellitus
(6)
Medicine
(6)
Medicine & Public Health
(6)
Aged
(5)
Diabetes Mellitus, Type 2 - Drug Therapy
(5)
Female
(5)
Internal Medicine
(5)
Metabolic Diseases
(5)
Risk Factors
(5)
Coronaviruses
(4)
Endocrinology
(4)
Insulin
(4)
Male
(4)
Middle Aged
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect

Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study

SGLT2-inhibitors are effective and safe in the elderly: The SOLD study

COVID-19 vaccines and blood glucose control: Friend or foe?

Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)

Thyrotoxicosis in patients with COVID-19: the THYRCOV study

Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis

Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists

l‐Carnitine: a nutritional modulator of glucocorticoid receptor functions

367-P: Cardiovascular Risk Categories in Patients with Diabetes According to 2019 ESC/EASD Guidelines in Clinical Practice: Use of a Dedicated App (AWARE)

Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort

Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population

I nuovi farmaci antidiabetici nelle persone che vivono con l’infezione da HIV

Update on vertebral fractures in pituitary diseases: from research to clinical practice

Biochemical Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors by Cardiovascular Risk Profile and Volume Status in a Real-World Diabetic Population

AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus

112 Safety and biochemical efficacy of sodium–glucose cotransporter 2 inhibitors based on cardiovascular risk profile and volume status in a real-world diabetic population

617 Effects of SGLT2 inhibitors on left and right ventricular function in a real-world diabetic population

Reply to letter to the editor by Bonaventura et al

COVID-19 ed endocrinologia: il caso della tiroide, del diabete e dell’ipovitaminosi D

Tissue glucocorticoid resistance/hypersensitivity syndromes

HIV-1 Protein Vpr Suppresses IL-12 Production from Human Monocytes by Enhancing Glucocorticoid Action: Potential Implications of Vpr Coactivator Activity for the Innate and Cellular Immunity Deficits Observed in HIV-1 Infection

Long-term treatment with glucagon-like peptide-1 (GLP-1) receptor agonists: a real-life study

Suchergebnisse filtern